Undersøgelsen omfattede 1481 patienter med varierende grad af hertil forbundne depressive symptomer (middelværdi før behandling lig 16, 6 ved Montgomery- Asberg Depression Rating Scale).
In a multinational, double-blind, comparative study of schizophrenia, schizoaffective, and related disorders which included 1,481 patients with varying degrees of associated depressive symptoms (baseline mean of 16.6 on the Montgomery-Asberg Depression Rating Scale), a prospective secondary